Evaluation of BRCA2 in the genetic susceptibility of familial esophageal cancer

Oncogene

Volumn 23, Issue 3, 2004, Pages 852-858

  Hu, Nan ^a   Wang, Chaoyu ^a   Han, Xiao You ^b   He, Li Ji ^c   Tang, Ze Zhong ^b   Giffen, Carol ^d   Emmert Buck, Michael R ^a   Goldstein, Alisa M ^a   Taylor, Philip R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SHANXI CANCER HOSPITAL   (China)

^c Yangcheng Cancer Hospital   (China)

^d INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

DNA sequencing; Familial; High risk; LOH; Mutation

Indexed keywords

BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BLOOD BANK; BLOOD DONOR; CONTROLLED STUDY; DNA SEQUENCE; ESOPHAGUS CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN, PAIR 13; DNA PRIMERS; ESOPHAGEAL NEOPLASMS; FEMALE; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; PEDIGREE;

EID: 1242272911     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207150     Document Type: Article

References (22)

1. Carter CL, Hu N, Wu M, Lin PZ, Murigande C and Bonney GE. (1992). J. Natl. Cancer Inst., 84, 771-776.
2. Fuks F, Milner J and Kouzarides T. (1998). Oncogene, 17, 2531-2534.
3. Harada H, Tanaka H, Shimada Y, Shinoda M, Imamura M and Ishizaki K. (1999). Cancer Res., 59, 3724-3729.
4. Hu N, Dawsey SM, Wu M, Bonney GE, He LJ, Han XY, Fu M and Taylor PR. (1992). Int. J. Epidemiol., 21, 877-882.
5. Hu N, Dawsey SM, Wu M and Taylor PR. (1991). Eur. J. Cancer, 27, 1336.
6. Hu N, Huang J, Emmert-Buck MR, Tang ZZ, Roth MJ, Wang C, Dawsey SM, Li G, Li WJ, Wang QH, Han XY, Ding T, Giffen C, Goldstein AM and Taylor PR. (2001). Clin. Cancer Res., 7, 883-891.
7. Hu N, Li G, Li WJ, Wang C, Goldstein AM, Tang ZZ, Roth MJ, Dawsey SM, Huang J, Wang QH, Ding T, Giffen C, Taylor PR and Emmert-Buck MR. (2002). Clin. Cancer Res., 8, 1121-1126.
8. Hu N, Roth MJ, Polymeropolous M, Tang ZZ, Emmert-Buck MR, Wang QH, Goldstein AM, Feng SS, Dawsey SM, Ding T, Zhuang ZP, Han XY, Ried T, Giffen C and Taylor PR. (2000). Genes Chromosomes Cancer, 27, 217-228.
9. Li G and He L. (1986). Genes and Disease, Proceedings of the First Sino-American Human Genetics Workshop. Science Press: Beijing, pp. 43-47.
10. Li G, Hu N, Goldstein AM, Tang ZZ, Roth MJ, Wang QH, Dawsey SM, Han XY, Ding T, Huang J, Giffen C, Taylor PR and Emmert-Buck MR. (2001). Genes Chromosomes Cancer, 31, 390-397.
11. Li JY. (1982). Natl. Cancer Inst. Monogr., 62, 113-120.
12. Li MH, Li P and Li PJ. (1980). Adv. Cancer Res., 33, 173-249.
13. Liede A and Narod SA. (2002). Hum. Mutat., 20, 413-424.
14. Marston NJ, Richards WJ, Hughes D, Bertwistle D, Marshall CJ and Ashworth A. (1999). Mol. Cell. Biol., 19, 4633-4642.
15. Nathanson KL, Wooster R, Weber BL and Nathanson KN. (2001). Nat. Med., 7, 552-556.
16. National Cancer Control Office (1980). Investigation of Cancer Mortality in China. People's Health Publishing House: Beijing, China.
17. Pyne MT, Brothman AR, Ward B, Pruss D, Hendrickson BC and Scholl T. (2000). J. Hum. Genet., 45, 351-357.
18. The Breast Cancer Linkage Consortium (1999). J. Natl. Cancer Inst., 91, 1310-1316.
19. Wang Y, Han XY, SU W, Wang Y, Zhu Y, Sasaba T, Nakachi K, Hoshiyama Y and Tagashira Y. (1993). Cancer Causes Control, 3, 107-113.
20. Wu M, Hu N and Wang XQ. (1989). Familial Cancer, Ist International Research Conference. CRC Press Inc.: Boca Raton, FL, pp. 187-200.
21. Yang H, Jeffrey PD, Miller J, Kinnucan E, Sun Y, Thoma NH, Zheng N, Chen PL, Lee WH and Pavletich NP. (2002). Science, 297, 1837-1848.
22. Zhi X, Szabo C, Chopin S, Suter N, Wang QS, Ostrander EA, Sinilnikova OM, Lenoir GM, Goldgar D and Shi YR. (2002). Hum. Mutat., 20, 474.